Výsledky vyhledávání - "Mathias Egermark"

Akademický článek

Overcoming Pilotitis in Digital Medicine at the Intersection of Data, Clinical Evidence, and Adoption

Autor: Mathias Egermark, Agata Blasiak, Alexandria Remus, Yoann Sapanel, Dean Ho

Publikováno v: Advanced Intelligent Systems, Vol 4, Iss 9, Pp n/a-n/a (2022)

Worldwide, digital medicine technologies are being developed at a rapid rate. While these digital medicine technologies offer the potential to transform and revolutionize health care, many are at risk of stalling and remaining in the pilot stage, kno

Externí odkaz: https://doaj.org/article/6462f99dce1a4638a4d5cbe54349e324

Zobrazit plný text záznamu

Patient satisfaction with the benefits of overactive bladder treatment: Exploration of influencing factors and development of a satisfaction assessment instrument

Autor: Deborah Kelley Fix, Norman Zinner, Patricia Koochaki, Mathias Egermark, Kathleen C. Kobashi

Publikováno v: Neurourology and Urodynamics. 30:62-68

Introduction Patient-reported outcome (PRO) instruments are useful for assessing treatment success in patients with overactive bladder (OAB). PROs such as the OAB Questionnaire (OAB-q) and Patient Perception of Bladder Condition (PPBC) focus more on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67932747ffb7636abe2b346d697e944f
https://doi.org/10.1002/nau.20890

Zobrazit plný text záznamu

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy

Autor: Patricia Koochaki, Kathleen C. Kobashi, Mathias Egermark, Ursula Ebinger, Andrea Viegas, Norman Zinner, E. Quebe-Fehling

Publikováno v: International Journal of Clinical Practice. 62:1664-1674

SUMMARY Introduction and objective: Patient perception of overactive bladder (OAB) treatment outcomes can be a useful indicator of benefit and may help drive persis- tence on treatment, which is known to be poor in OAB. It remains unclear whether OAB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54f7c2b39cfa706d63d0cd5d12a48682
https://doi.org/10.1111/j.1742-1241.2008.01893.x

Zobrazit plný text záznamu

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study With Tolterodine and Darifenacin in Healthy Participants ≥50 Years

Autor: Mathias Egermark, Jose Brum, Brian Olshansky, Andrea Viegas, Ludmyla Rekeda, Ursula Ebinger

Publikováno v: Journal of Cardiovascular Pharmacology and Therapeutics. 13:241-251

Antimuscarinics, used commonly to treat overactive bladder, may differ in their potential to increase heart rate via effects on cardiac muscarinic M2 receptors. This prospective, 3-way crossover, randomized, double-blind study assessed the heart rate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9d68160b489d8e3c23f339aff1b5e3
https://doi.org/10.1177/1074248408325404

Zobrazit plný text záznamu

Time-to-effect with darifenacin in overactive bladder: a pooled analysis

Autor: Jenelle Foote, Vik Khullar, Yodit Seifu, Mathias Egermark

Publikováno v: International urogynecology journal. 22(12)

This study was conducted to assess time-to-effect with darifenacin in patients with overactive bladder (OAB). Efficacy and safety data were pooled from 1,059 patients (19–88 years, 85% women) randomized to darifenacin 7.5 or 15 mg once daily or mat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247a4fe651e955f150e5786572ae8c05
https://pubmed.ncbi.nlm.nih.gov/22006023

Zobrazit plný text záznamu

Patient satisfaction with the benefits of overactive bladder treatment: exploration of influencing factors and development of a satisfaction assessment instrument

Autor: Norman, Zinner, Kathleen, Kobashi, Patricia, Koochaki, Deborah, Fix, Mathias, Egermark

Publikováno v: Neurourology and urodynamics. 30(1)

Patient-reported outcome (PRO) instruments are useful for assessing treatment success in patients with overactive bladder (OAB). PROs such as the OAB Questionnaire (OAB-q) and Patient Perception of Bladder Condition (PPBC) focus more on OAB symptoms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73536febb6d185e65698cf7c35793465
https://pubmed.ncbi.nlm.nih.gov/22237348

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání